ESMO 2022 Conference Coverage
ESMO 2022 on the NICHE-2 Study: Neoadjuvant Immune Checkpoint Inhibition in Locally Advanced dMMR Colon Cancer
By
ESMO 2022 Conference Coverage
FEATURING
Myriam Chalabi
By
ESMO 2022 Conference Coverage
FEATURING
Myriam Chalabi
Login to view comments.
Click here to Login
GI